Your browser doesn't support javascript.
loading
Single-arm, neoadjuvant, phase II trial of pertuzumab and trastuzumab administered concomitantly with weekly paclitaxel followed by 5-fluoruracil, epirubicin, and cyclophosphamide (FEC) for stage I-III HER2-positive breast cancer.
Foldi, Julia; Mougalian, Sarah; Silber, Andrea; Lannin, Donald; Killelea, Brigid; Chagpar, Anees; Horowitz, Nina; Frederick, Courtney; Rispoli, Lawrence; Burrello, Trisha; Abu-Khalaf, Maysa; Sabbath, Kert; Sanft, Tara; Brandt, Debra S; Hofstatter, Erin W; Hatzis, Christos; DiGiovanna, Michael P; Pusztai, Lajos.
Afiliación
  • Foldi J; Yale Cancer Center, Yale School of Medicine, 333 Cedar St., PO Box 208032, New Haven, CT, 05620, USA.
  • Mougalian S; Yale Cancer Center, Yale School of Medicine, 333 Cedar St., PO Box 208032, New Haven, CT, 05620, USA.
  • Silber A; Yale Cancer Center, Yale School of Medicine, 333 Cedar St., PO Box 208032, New Haven, CT, 05620, USA.
  • Lannin D; Yale Cancer Center, Yale School of Medicine, 333 Cedar St., PO Box 208032, New Haven, CT, 05620, USA.
  • Killelea B; Yale Cancer Center, Yale School of Medicine, 333 Cedar St., PO Box 208032, New Haven, CT, 05620, USA.
  • Chagpar A; Yale Cancer Center, Yale School of Medicine, 333 Cedar St., PO Box 208032, New Haven, CT, 05620, USA.
  • Horowitz N; Yale Cancer Center, Yale School of Medicine, 333 Cedar St., PO Box 208032, New Haven, CT, 05620, USA.
  • Frederick C; Yale Cancer Center, Yale School of Medicine, 333 Cedar St., PO Box 208032, New Haven, CT, 05620, USA.
  • Rispoli L; Yale Cancer Center, Yale School of Medicine, 333 Cedar St., PO Box 208032, New Haven, CT, 05620, USA.
  • Burrello T; Yale Cancer Center, Yale School of Medicine, 333 Cedar St., PO Box 208032, New Haven, CT, 05620, USA.
  • Abu-Khalaf M; Yale Cancer Center, Yale School of Medicine, 333 Cedar St., PO Box 208032, New Haven, CT, 05620, USA.
  • Sabbath K; Yale Cancer Center, Yale School of Medicine, 333 Cedar St., PO Box 208032, New Haven, CT, 05620, USA.
  • Sanft T; Yale Cancer Center, Yale School of Medicine, 333 Cedar St., PO Box 208032, New Haven, CT, 05620, USA.
  • Brandt DS; Yale Cancer Center, Yale School of Medicine, 333 Cedar St., PO Box 208032, New Haven, CT, 05620, USA.
  • Hofstatter EW; Yale Cancer Center, Yale School of Medicine, 333 Cedar St., PO Box 208032, New Haven, CT, 05620, USA.
  • Hatzis C; Yale Cancer Center, Yale School of Medicine, 333 Cedar St., PO Box 208032, New Haven, CT, 05620, USA.
  • DiGiovanna MP; Yale Cancer Center, Yale School of Medicine, 333 Cedar St., PO Box 208032, New Haven, CT, 05620, USA.
  • Pusztai L; Yale Cancer Center, Yale School of Medicine, 333 Cedar St., PO Box 208032, New Haven, CT, 05620, USA. lajos.pusztai@yale.edu.
Breast Cancer Res Treat ; 169(2): 333-340, 2018 Jun.
Article en En | MEDLINE | ID: mdl-29396664
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Hidrocarburos Aromáticos con Puentes / Terapia Neoadyuvante / Taxoides / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos Límite: Adult / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Treat Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Hidrocarburos Aromáticos con Puentes / Terapia Neoadyuvante / Taxoides / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos Límite: Adult / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Treat Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos